Allogeneic Valve Transplantation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-50
SponsorBoston Children's Hospital
About this trial
Valves will be taken from hearts donated by organ donors, and implanted into patients who need a new heart valve.
Eligibility criteria
Qualifiers
Patients requiring aortic, pulmonary, mitral or tricuspid valve replacement.
Pediatric patients 30 days or older and < 18 years, and adult patients 18-50 yrs.
Insufficient options are available for valve replacement
Discussion with patient /family - option for durable valve rather than traditional prosthesis
Disqualifiers
Age < 30 days
Irreversible multisystem organ failure; or additive effects of the multiple systems affected making transplant survival unlikely
Progressive systemic disease with early mortality (genetic/metabolic, idiopathic, syndromic)
Morbid obesity (BMI>35)
Trial design
Treatments tested in this trial
- Valve transplant
Treatment groups
4 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov